Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Quest Diagnostics
(NY:
DGX
)
155.53
-1.44 (-0.92%)
Streaming Delayed Price
Updated: 3:39 PM EDT, Sep 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Quest Diagnostics
< Previous
1
2
3
4
5
6
7
8
Next >
QDEL Stock Alert: What Is Going on With Quidel Today?
December 20, 2021
The nearing holidays mean an increasing demand for Covid-19 testing kits. Leading provider Quidel is seeing QDEL stock rise as a result.
Via
InvestorPlace
Price Over Earnings Overview: Quest Diagnostics
December 14, 2021
In the current session, Quest Diagnostics Inc. (NYSE:DGX) is trading at $163.60, after a 0.21% gain. Over the past month, the stock increased by 10.55%, and in the past...
Via
Benzinga
Overview Of Value Stocks In The Healthcare Sector
November 29, 2021
What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...
Via
Benzinga
7 Stocks to Buy as America Lifts Its Travel Ban
November 19, 2021
With the Biden administration making the move to open U.S. land borders with Canada and Mexico, these stocks to buy can get a boost.
Via
InvestorPlace
Exposures
COVID-19
Why This Diagnostics Stock Is a Buy
November 18, 2021
Quest Diagnostics beat analysts' estimates in the third quarter and raised its guidance for this year again.
Via
The Motley Fool
The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline
August 18, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
August 17, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc...
Via
Benzinga
Wall Street Crime And Punishment: The Blood On Elizabeth Holmes' Fingers
November 12, 2021
Does crime pay? Wall Street Crime and Punishment is a weekly series by Benzinga's Phil Hall chronicling the bankers, brokers and financial ne’er-do-wells whose ambition...
Via
Benzinga
What 5 Analyst Ratings Have To Say About Quest Diagnostics
October 26, 2021
Within the last quarter, Quest Diagnostics (NYSE:DGX) has observed the follow...
Via
Benzinga
Quest Diagnostics Inc (DGX) Q3 2021 Earnings Call Transcript
October 21, 2021
DGX earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Quest Diagnostics: Q3 Earnings Insights
October 21, 2021
Quest Diagnostics (NYSE:DGX) reported its Q3 earnings results on Thursday, October 21, 2021 at 06:45 AM. Here's what investors need to know about the announcement....
Via
Benzinga
Quest Raises FY21 Outlook Again On Strong COVID-19 Volumes In Q3
October 21, 2021
Quest Diagnostics Incorporated (NYSE: DGX) has posted a better-than-expected Q3 adjusted EPS of $3.96, down 7.9% Y/Y, beating the consensus estimate of $2.87. Sales...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: FDA Authorizes Moderna, J&J Booster Shots; Regulatory Approvals For Bristol-Myers Squibb, Sanofi-Regeneron; Ventyx IPO
October 21, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus CDC Committee Recommends Approval Of Merck, Pfizer's Pneumococcal Vaccine...
Via
Benzinga
Exposures
Product Safety
Earnings Outlook For Quest Diagnostics
October 20, 2021
Quest Diagnostics (NYSE:DGX) is set to give its latest quarterly earnings report on Thursday, 2021-10-21. Here's what investors need to know before the announcement. Analysts...
Via
Benzinga
Price Over Earnings Overview: Quest Diagnostics
October 19, 2021
Right now, Quest Diagnostics Inc. (NYSE:DGX) share price is at $145.77, after a 1.43% gain. Moreover, over the past month, the stock fell by 5.60%, but in the past...
Via
Benzinga
The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs
October 18, 2021
Biotech stocks rebounded in the week ended Oct. 15, bouncing from third straight weekly losses. The strength came amid a broader market rally and some sector-specific news....
Via
Benzinga
Exposures
Product Safety
Earnings Scheduled For October 21, 2021
October 21, 2021
Companies Reporting Before The Bell • Tri Pointe Homes (NYSE:TPH) is estimated to report quarterly earnings at $0.89 per share on revenue of $946.97 million. •...
Via
Benzinga
Overview Of Value Stocks In The Healthcare Sector
October 04, 2021
What is a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...
Via
Benzinga
The Delta Variant Has Made Quest Diagnostics Indispensable
September 29, 2021
On the back of steady demand for COVID-19 testing, Quest Diagnostics bumped up its guidance for this year.
Via
The Motley Fool
Exposures
COVID-19
Instead of Buying Dogecoin, Invest in These 3 Companies That Are Bullish on Blockchain Technology
September 16, 2021
These businesses have exposure to blockchain technology and they're safer options than buying crypto directly.
Via
The Motley Fool
Quest Diagnostics Updates 2021 Outlook On Surging Demand Of COVID-19 Tests
September 09, 2021
Since Quest Diagnostics Incorporated (NYSE: DGX) reported its Q2 FY21 financial results, COVID-19 molecular testing volumes were stronger than anticipated through the...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test
September 10, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9) Adagio Therapeutics, Inc. (...
Via
Benzinga
Underwhelming: Tepid Jobs Data Could Add New Variable To Fed Policy Equation
September 03, 2021
That hissing noise you hear is the air being let out of the market’s tires after an epically disappointing August jobs report. The Delta variant seems to be sinking its...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
September 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:...
Via
Benzinga
Exposures
COVID-19
10 Biggest Price Target Changes For Wednesday
September 01, 2021
Rosenblatt raised Ambarella, Inc. (NASDAQ:AMBA) p...
Via
Benzinga
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
September 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc...
Via
Benzinga
Exposures
Product Safety
Quest Diagnostics, eMed Team Up To Offer COVID-19 Rapid Antigen Testing At Workplaces
August 11, 2021
Telehealth company eMed and Quest Diagnostics Inc (NYSE: DGX) have collaborated for clinician-guided rapid antigen testing for COVID-19 in...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself
September 03, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Abbott Laboratories (NYSE:...
Via
Benzinga
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
September 02, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) AbbVie Inc. (NASDAQ: ABBV...
Via
Benzinga
Exposures
COVID-19
Product Safety
Stocks That Hit 52-Week Highs On Tuesday
August 17, 2021
Before 10 a.m. ET on Tuesday, 55 companies set new 52-week highs. Points of Interest: Apple (NASDAQ:AAPL) was the largest company by market cap to set a new 52-week...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.